PubRank

Emi Takashita

Author PubWeight™ 27.98‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Characterization of H7N9 influenza A viruses isolated from humans. Nature 2013 3.71
2 Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A/H3N2 virus hemagglutinin. J Virol 2004 2.11
3 Genetic diversity of influenza B virus: the frequent reassortment and cocirculation of the genetically distinct reassortant viruses in a community. J Med Virol 2004 1.30
4 Molecular evolutionary analysis of the influenza A(H1N1)pdm, May-September, 2009: temporal and spatial spreading profile of the viruses in Japan. PLoS One 2010 1.28
5 The role of G-protein-coupled receptor kinase 5 in pathogenesis of sporadic Parkinson's disease. J Neurosci 2006 1.28
6 Reactivation of herpes simplex virus type 1 and varicella-zoster virus and therapeutic effects of combination therapy with prednisolone and valacyclovir in patients with Bell's palsy. Laryngoscope 2007 1.22
7 A nationwide epidemic of influenza C virus infection in Japan in 2004. J Clin Microbiol 2007 1.13
8 Replication-incompetent influenza A viruses that stably express a foreign gene. J Gen Virol 2011 1.12
9 Monitoring and characterization of oseltamivir-resistant pandemic (H1N1) 2009 virus, Japan, 2009-2010. Emerg Infect Dis 2011 1.12
10 A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir. Virol J 2010 1.06
11 A mutation on influenza C virus M1 protein affects virion morphology by altering the membrane affinity of the protein. J Virol 2007 1.00
12 Identification of an amino acid residue on influenza C virus M1 protein responsible for formation of the cord-like structures of the virus. J Gen Virol 2004 0.98
13 Evaluation of a new rapid antigen test using immunochromatography for detection of human metapneumovirus in comparison with real-time PCR assay. J Clin Microbiol 2009 0.97
14 Longitudinal course of human metapneumovirus antibody titers and reinfection in healthy adults. J Med Virol 2010 0.90
15 Evaluation of influenza virus A/H3N2 and B vaccines on the basis of cross-reactivity of postvaccination human serum antibodies against influenza viruses A/H3N2 and B isolated in MDCK cells and embryonated hen eggs. Clin Vaccine Immunol 2012 0.89
16 A novel bivalent vaccine based on a PB2-knockout influenza virus protects mice from pandemic H1N1 and highly pathogenic H5N1 virus challenges. J Virol 2013 0.84
17 Influenza C virus NS1 protein upregulates the splicing of viral mRNAs. J Virol 2009 0.82
18 Rapid discrimination of oseltamivir-resistant 275Y and -susceptible 275H substitutions in the neuraminidase gene of pandemic influenza A/H1N1 2009 virus by duplex one-step RT-PCR assay. J Med Virol 2011 0.82
19 Role of the CM2 protein in the influenza C virus replication cycle. J Virol 2010 0.81
20 Isolation of an influenza C virus introduced into Japan by a traveler from Malaysia. J Clin Microbiol 2005 0.81
21 A single E105K mutation far from the active site of influenza B virus neuraminidase contributes to reduced susceptibility to multiple neuraminidase-inhibitor drugs. Biochem Biophys Res Commun 2012 0.80
22 Conformational maturation of the nucleoprotein synthesized in influenza C virus-infected cells. Virus Res 2006 0.79
23 Development and evaluation of a whole virus-based enzyme-linked immunosorbent assay for the detection of human metapneumovirus antibodies in human sera. J Virol Methods 2009 0.78
24 Intracellular localization of influenza C virus NS2 protein (NEP) in infected cells and its incorporation into virions. Arch Virol 2009 0.78
25 Comparison of virus isolation using the Vero E6 cell line with real-time RT-PCR assay for the detection of human metapneumovirus. BMC Infect Dis 2010 0.75
26 Human-to-Human Transmission of Influenza A(H3N2) Virus with Reduced Susceptibility to Baloxavir, Japan, February 2019. Emerg Infect Dis 2019 0.75
27 Mutations at the monomer-monomer interface away from the active site of influenza B virus neuraminidase reduces susceptibility to neuraminidase inhibitor drugs. J Infect Chemother 2013 0.75
28 Seroprevalence of a novel influenza A (H3N2) variant virus in the Japanese population. Jpn J Infect Dis 2013 0.75